Advances in neurodegenerative science have pointed to new paths in the development of medicines that have the potential to dramatically improve patient quality of life. These advances are contributing to innovative therapeutic approaches to diseases like Parkinson’s, ALS, and Alzheimer’s. This session will feature leading innovators who will discuss the latest advancements in diverse approaches to neurodegenerative diseases. Attendees will learn about the evolving landscape of neurodegenerative disease research and development, the potential of novel targets, and the implications for future treatment and investment opportunities.​